Medication management and education of osteoarthritis patients: evaluation of a role for community pharmacists
|Institution:||University of Sydney|
|Chief Investigator:||Dr Tim Chen|
Arthritis is the third most common cause of disability burden in Australia, costing the community $9 billion per annum. Osteoarthritis is the most common form of arthritis, however, patients frequently do not receive adequate pain relief primarily because their pain is not properly assessed and pharmacological therapy does not always comply with evidenced-based practice. Pharmacist-conducted medication reviews, in cooperation with medical practitioners, optimise medication use and improve quality of life. The accessibility of the community pharmacist enables them to assist osteoarthritic patients by conducting pain assessments, medication reviews and counselling on a regular basis, in collaboration with other health-care professionals.